Immunohistochemistry (IHC) and immunofluorescence (IF) assays of NGF confirmed that the pancreatic tumours exhibited significantly higher NGF immunoreactivity compared to normal pancreas (Supplementary Fig. 1b). The gene discussed is NGF; the disease is pancreatic neoplasm.